Skip to content

UCHL1 Promotes M1 Macrophage Polarization and Inflammation in Chronic Rhinosinusitis by Stabilizing HIF-1α.

Sep 2026 · Cell Biochemistry and Biophysics · 0 citations · 34 references
Medicine

TL;DR

Findings indicate that UCHL1 drives M1 macrophage polarization and exacerbates CRS inflammation by stabilizing HIF‑1α through deubiquitination, highlighting UCHL1 as a potential therapeutic target in CRS.

View source

Similar papers

Open access Sep 2026

TIPE2 modulates macrophage polarization via targeting Rac1/NF-kB and PI3K/AKT pathways

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory disorder that affects up to 12% of the general population. It is associated with significant morbidity and a considerable burden on the healthcare system. Tumor necrosis factor -induced protein 8-like 2 (TIPE2) is an immune-related protein...

Hui Wang, Ling-Han Huang · 0 citations
Open access Oct 2026

Disruption of p62 ubiquitination by α-methylene-γ-butyrolactone enhances Keap1 lysosomal degradation for ulcerative colitis therapy.

Ulcerative colitis (UC) is an intestinal inflammatory disorder primarily driven by M1 macrophage activation and oxidative stress. p62/Sequestosome-1, a multifunctional autophagy adaptor protein, plays a critical role in regulating autophagy and inflammation. α-Methylene-γ-butyrolactone (αMγB), a conserved structural mo...

Ke-Gang Linghu, Da-Song Wang, Tian Zhang et al. · 0 citations
Sep 2026

IGF2BP3 drives macrophage M1 polarization to promote intracranial aneurysm rupture through m6A-mediated NPY1R stabilization.

BACKGROUND The progression of intracranial aneurysm (IA) was closely associated with an imbalance in M1/M2 macrophage polarization. Neuropeptide Y receptor 1 (NPY1R) was involved in regulating IA development. However, NPY1R in IA-associated macrophages and its impact on macrophage polarization remain to be elucidated....

Jian He, Ting Tang, Yong-Hong Duan et al. · 0 citations
Aug 2026

Targeting PKM2 by (+)-homocrepidine A restrains glycolytic reprogramming and reshapes macrophage fate to alleviate acute lung injury.

HCA is identified as the bioactive enantiomer responsible for the anti-ALI activity of HCA and PKM2-mediated immunometabolic reprogramming underlies its protective effects, establishing PKM2 as a promising therapeutic target and (+)-HCA as a potential lead compound for ALI treatment.

Rong-Rong Dong, Yu Yang, Na Luo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.